Original Articles: Atopic Dermatitis, Urticaria and Skin Disease
To add the references below to your reference management program: 1. Download the file; 2. Open your reference management program or EndNote; 3. Select File and import |
135 Articles |
-
T Cells Induce Prolonged Downregulation of Barrier Molecules in a Mouse Model of Allergic Contact Dermatitis
Vaher, H., Gadsbøll, A.-S.Ø., Seibel, A.T., et al. Allergy. First published: 14 December 2024
-
Tralokinumab Treatment in Adult Atopic Dermatitis Patients: 28-Week Evaluation of Clinical Effectiveness, Safety, Serum Proteins and Total IgE Levels
Dekkers, C., Zuithoff, N., Bakker, D., et al. Allergy. First published: 14 December 2024
-
Comparison of CD30L and OX40L Reveals CD30L as a Promising Therapeutic Target in Atopic Dermatitis
Gupta, R.K., Figueroa, D.S., Ay, F., et al. Allergy. First published: 26 November 2024
-
Fecal microbiota transplantation against moderate-to-severe atopic dermatitis: A randomized, double-blind controlled explorer trial
Liu X, Luo Y, Chen X, et al. Allergy. First published: 29 October 2024
-
Long-term efficacy and safety of stapokibart for moderate-to-severe atopic dermatitis: 52-week results from a phase 3 trial
Zhao Y, Zhang L, Wu L, et al. Allergy. First published: 25 October 2024
-
Validity, reliability and responsiveness of digital visual analogue scales for chronic spontaneous urticaria monitoring: A CRUSE® mobile health study
Sousa-Pinto B, Ramanauskaite A, Neisinger S, et al. Allergy. First published: 24 October 2024
-
Omalizumab is effective and safe in chronic inducible urticaria (CIndU): Real-world data from a large multi-national UCARE study
Soegiharto R, Alizadeh Aghdam M, Sørensen JA, et al. Allergy. First published: 08 October 2024
-
Evaluation of dupilumab on the disease burden in children and adolescents with atopic dermatitis: A population-based cohort study
Tsai S-C, Gaffin JM, Hawryluk EB, et al. Allergy. First published: 21 August 2024
-
Infantile colic is associated with development of later constipation and atopic disorders
Stokholm J, Thorsen J, Schoos A-M, et al. Allergy. First published: 19 August 2024
-
Alopecia areata exhibits cutaneous and systemic OX40 activation across atopic backgrounds
Kim M, Del Duca E, Dahabreh D, et al. Allergy. First published: 08 August 2024
-
Characterization of omalizumab updosing patterns and predictive factors in chronic spontaneous urticaria: A prospective multicentric observational study
Pierrard G, Bernier C, Du-Thanh A, et al. Allergy. First published: 26 July 2024
-
In chronic spontaneous urticaria, increased Galectin-9 expression on basophils and eosinophils is linked to high disease activity, endotype-specific markers, and response to omalizumab treatment
Ji J, Tang M, Zhao Y, et al. Allergy. First published: 18 July 2024
-
Evolution of pathologic B-cell subsets and serum environment-specific sIgEs in patients with atopic dermatitis and controls, from infancy to adulthood
Czarnowicki T, David E, Yamamura K, et al. Allergy. First published: 14 July 2024
-
Altered levels of phospholipases C, diacylglycerols, endocannabinoids, and N-acylethanolamines in patients with hereditary angioedema due to FXII mutation
Ferrara AL, Palestra F, Piscitelli F, et al. Allergy. First published: 27 June 2024
-
The stimulation of TH2 cells results in increased IL-5 and IL-13 production via the H4 receptor
Nikolouli E, Mommert S, Dawodu DM, et al. Allergy. First published: 10 June 2024
-
Mapping the immune cell landscape of severe atopic dermatitis by single-cell RNA-seq
Jin S-P, Lee K, Bang YJ, et al. Allergy. First published: 31 May 2024
-
Meteorin-like protein/METRNL/Interleukin-41 ameliorates atopic dermatitis-like inflammation
Huang D, Liu X, Gao X, et al. Allergy. First published: 10 May 2024
-
Lin-CD117+CD34+FcεRI+ progenitor cells are increased in chronic spontaneous urticaria and predict clinical responsiveness to anti-IgE therapy
Ridge K, Moran B, Alvarado-Vazquez PA, et al. Allergy. First published: 17 April 2024
-
Inhibition of RNase 7 by RNase inhibitor promotes inflammation and Staphylococcus aureus growth: Implications for atopic dermatitis
Rademacher F, Scheel A, Gläser R, et al. Allergy. First published: 19 April 2024
-
Targeting IL-13 with tralokinumab normalizes type 2 inflammation in atopic dermatitis both early and at 2 years
Guttman-Yassky E, Kabashima K, Staumont-Salle D, et al. Allergy. First published: 02 April 2024
-
RNA-sequencing of paired tape-strips and skin biopsies in atopic dermatitis reveals key differences
Fritz B, Halling A-S, Cort I-P, et al. Allergy. First published: 13 March 2024
-
Epidermal barrier impairment predisposes for excessive growth of the allergy-associated yeast >Malassezia on murine skin
Ruchti F, Zwicky P, Becher B, Dubrac S, LeibundGut-Landmann S. Allergy. First published: 22 February 2024
-
Dupilumab-associated ocular surface disease is characterized by a shift from Th2/Th17 toward Th1/Th17 inflammation
Thormann K, Lüthi A-S, Deniau F, et al. Allergy. First published: 05 February 2024
-
Regulation of immune response genes in the skin of allergic and clinically tolerant individuals exposed to p-phenylenediamine
Meisser SS, Mitamura Y, Altunbulakli C, et al. Allergy. First published: 23 January 2024
-
Propionate alleviates itch in murine models of atopic dermatitis by modulating sensory TRP channels of dorsal root ganglion
Xu Y, Qiu Z, Gu C, et al. Allergy. First published: 02 January 2024
-
Forsythia velutina Nakai extract: A promising therapeutic option for atopic dermatitis through multiple cell type modulation
Kwon Y, Kang YJ, Kwon J, et al. Allergy. First published: 01 December 2023
-
Efficacy outcomes in trials with prophylactic hereditary angioedema therapy: A systematic review
Petersen, R.S., Fijen, L.M. and Cohn, D.M. Allergy. First published: 27 November 2023
-
Efficacy and safety of abrocitinib in patients with moderate-to-severe atopic dermatitis and comorbid allergies
Schmid-Grendelmeier P, Gooderham MJ, Hartmann K, et al. Allergy. First published: 21 November 2023
-
Clinical and molecular effects of oral CCR4 antagonist RPT193 in atopic dermatitis: A Phase 1 study
Bissonnette R, DuBois J, Facheris P, et al. Allergy. First published: 20 November 2023
-
Development of a clinical algorithm to predict phenotypic switches between atopic dermatitis and psoriasis (the “Flip-Flop” phenomenon)
Müller S, Welchowski T, Schmid M, et al. Allergy. First published: 21 October 2023
-
Cascade of atopic dermatitis comorbidities in children after birth for 15 years
Kim JH, Lee E, Ha EK, et al. Allergy. First published: 16 October 2023
-
Household laundry detergents disrupt barrier integrity and induce inflammation in mouse and human skin
Rinaldi, AO, Li, M, Barletta, E, et al. Allergy. First published: 27 September 2023
-
Electrical impedance spectroscopy detects skin barrier dysfunction in childhood atopic dermatitis
Sasaki, M, Sundberg, M, Frei, R, et al. Allergy. First published: 27 September 2023
-
Temporal relationships between Staphylococcus aureus colonization, filaggrin expression, and pediatric atopic dermatitis
Dahal, A, Chang, WC, Almasri, C, et al. Allergy. First published: 31 August 2023
-
TNF-like weak inducer of apoptosis inhibition is comparable to IL-13 blockade in ameliorating atopic dermatitis inflammation
Gupta, RK, Miller, J, Croft, M. Allergy. First published: 31 August 2023
-
Efficacy and safety of on-demand versus daily rupatadine in chronic spontaneous urticaria: A randomized trial
Weller, K, Gimenez-Arnau, AM, Baron, J, et al. Allergy. First published: 19 August 2023
-
Intrapatient comparison of atopic dermatitis skin transcriptome shows differences between tape-strips and biopsies
Del Duca, E, He, H, Liu, Y, et al. Allergy. First published: 14 August 2023
-
Topical corticosteroids inhibit allergic skin inflammation but are ineffective in impeding the formation and expansion of resident memory T cells
Ono, E, Lenief, V, Lefevre, M-A, et al. Allergy. First published: 04 August 2023
-
Immunoglobulin E autoantibodies in atopic dermatitis associate with Type-2 comorbidities and the atopic march
Kortekaas Krohn, I, Badloe, FMS, Herrmann, N, et al. Allergy. First published: 24 July 2023
-
Shotgun metagenomic sequencing on skin microbiome indicates dysbiosis exists prior to the onset of atopic dermatitis
Chaudhary, PP, Myles, IA, Zeldin, J, et al. Allergy. First published: 08 July 2023
-
Anti-heat shock protein 10 IgG in chronic spontaneous urticaria: Relation with miRNA-101-5p and platelet-activating factor
Choi, BY, Yang, E-M, Jung, H-W, et al. Allergy. First published: 07 July 2023
-
Spatial transcriptomics combined with single-cell RNA-sequencing unravels the complex inflammatory cell network in atopic dermatitis
Mitamura, Y, Reiger, M, Kim, J, et al. Allergy. First published: 14 June 2023
-
Arsenic exposure and pruritus: Evidence from observational, interventional, and mendelian randomization studies
Huang, X, Xiao, Y, Jing, D, et al. Allergy. First published: 02 May 2023
-
Age of onset defines two distinct profiles of atopic dermatitis in adults
Facheris, P., Da Rosa, J.C., Pagan, A.D., et al. Allergy. First published: 09 April 2023
-
Dupilumab but not cyclosporine treatment shifts the microbiome towards a healthy skin flora in patients with moderate to severe atopic dermatitis
Hartmann, J., Moitinho-Silva, L., Sander, N., et al. Allergy. First published: 09 April 2023
-
Atopic dermatitis: correlation of distinct risk factors with age of onset in adulthood compared to childhood
Maintz, L., Schmitz, M.-T., Herrmann, N., et al. Allergy. First published: 22 March 2023
-
Dupilumab-associated ocular surface disease in atopic dermatitis patients: clinical characteristics, ophthalmic treatment response, and conjunctival goblet cell analysis
Achten, R., Thijs, J., van der Wal, M., et al. Allergy. First published: 19 March 2023
-
Microglia–neuron interactions promote chronic itch via the NLRP3-IL-1β-GRPR axis
Liu, X, Wang, Y, Zeng, Y, et al. Allergy. First published: 06 March 2023
-
Effects of topical corticosteroid vs. tacrolimus on insulin sensitivity and bone homeostasis in adults with atopic dermatitis – a randomized controlled study
Gether, L., Storgaard, H., Kezic, S., et al. Allergy. First published: 23 February 2023
-
The skin microbiome in the first year of life and its association with atopic dermatitis
Rapin, A., Rehbinder, E.M., Macowan, M., et al. Allergy. First published: 13 February 2023
-
IL-13, periostin and dipeptidyl-peptidase-4 reveal endotype-phenotype associations in atopic dermatitis
Maintz, L., Welchowski, T., Herrmann, N., et al. Allergy. First published: 17 January 2023
-
Staphylococcus aureus causes aberrant epidermal lipid composition and skin barrier dysfunction
Kim, J., Kim, B.E., Berdyshev, E., et al. Allergy. First published: 07 January 2023
-
Autologous Th2-polarized lymphocytes induce atopic dermatitis lesions in non-atopic human skin xenotransplants
Keren, A., Reich, K., Bertolini, M., et al. Allergy. First published: 04 January 2023
-
IgG memory B cells expressing IL4R and FCER2 are associated with atopic diseases
Aranda, C.J., Gonzalez-Kozlova, E., Saunders, S.P., et al. Allergy. First published: 29 November 2022
-
Anti-kit antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria
Terhorst-Molawi, D., Hawro, T., Grekowitz, E., et al. Allergy. First published: 16 November 2022
-
RAB25 coordinates filaggrin-containing keratohyalin granule maturation and affects atopic dermatitis severity
Jeong, H., Lee, N., Uhm, C., et al. Allergy. First published: 16 November 2022
-
Dysregulated lipidome of sebum in patients with atopic dermatitis
Yin, H., Qiu, Z., Zhu, R., et al. Allergy. First published: 29 October 2022
-
Scalp biomarkers during dupilumab treatment support Th2 pathway pathogenicity in alopecia areata
Renert-Yuval, Y., Pavel, A.B., Del Duca, E., et al. Allergy. First published: 22 October 2022
-
Emollients for prevention of atopic dermatitis; 5-year findings from the BEEP randomised trial
Bradshaw, L.E., Wyatt, L.A., Brown, S.J., et al. Allergy. First published: 19 October 2022
-
Specific IgE against the house dust mite allergens Der p 5, 20 and 21 influences the phenotype and severity of atopic diseases
Walsemann, T., Böttger, M., Traidl, S., et al. Allergy. First published: 14 October 2022
-
Delayed type hypersensitivity reactions to various allergens may differently model inflammatory skin diseases
Pavel, A.B., Del Duca, E., Cheng, J., et al. Allergy. First published: 30 September 2022
-
Skin biomarkers predict development of atopic dermatitis in infancy
Rinnov, M.R., Halling, A.-S., Gerner, T., et al. Allergy. First published: 16 September 2022
-
Early initiation of short-term emollient use for the prevention of atopic dermatitis in high risk infants – the STOP AD randomised controlled trial
Chaoimh, C.N., Lad, D., Nico, C., et al. Allergy. First published: 23 August 2022
-
Molecular networks in atopic mothers impact the risk of infant atopy
Schedel, M., Leach, S.M., Strand, M.J., et al. Allergy. First published: 22 August 2022
-
Single-cell profiles reveal distinctive immune response in atopic dermatitis in contrast to psoriasis
Zhang, B., Roesner, L.M., Traidl, S., et al. Allergy. First published: 20 August 2022
-
The abundance of Ruminococcus bromii is associated with faecal butyrate levels and atopic dermatitis in infancy
Sasaki, M., Schwab, C., Ramirez Garcia, A., et al. Allergy. First published: 02 August 2022
-
Tonsillar transcriptional profiles in atopic and non-atopic subjects
Hanif, T., Ivaska, L.E., Ahmad, F., et al. Allergy. First published: 28 July 2022
-
Patient-centered dupilumab dosing regimen leads to successful dose reduction in persistently controlled atopic dermatitis
Spekhorst, L.S., Bakker, D., Drylewicz, J., et al. Allergy. First published: 15 July 2022
-
Dupilumab significantly improves skin barrier function in patients with moderate-to-severe atopic dermatitis
Berdyshev, E., Goleva, E., Bissonnette, R., et al. Allergy. First published: 11 July 2022
-
Development of the cold urticaria activity score
Ahsan, D. M., Altrichter, S., Gutsche, A., et al. Allergy. First published: 11 April 2022
-
Circadian rhythm affects the magnitude of contact hypersensitivity response in mice
Miyake, T., Egawa, G., Chow, Z., et al. Allergy. First published: 15 April 2022
-
Humoral immune response of Sinopharm/BBIBP COVID-19 vaccination before and after the booster immunization
Cheng, Z.J., Huang, H., Zheng, P., et al. Allergy. First published: 07 March 2022
-
Risk factors for systemic reactions in typical cold urticaria: results from the COLD-CE study
Bizjak, M., Košnik, M., Dinevski, D., et al. Allergy. First published: 04 December 2021
-
Sustained safety and efficacy of ligelizumab in patients with chronic spontaneous urticaria: A one-year extension study
Maurer, M, Giménez-Arnau, A, Bernstein, JA, et al. Allergy. First published: 13 November 2021
-
Heterogeneous origin of IgE in atopic dermatitis and psoriasis revealed by B cell receptor repertoire analysis
Luo, L, Luo, Y, Xu, J, et al. Allergy. First published: 05 November 2021
-
Impaired skin barrier and allergic sensitization in early infancy
Wärnberg Gerdin, S, Lie, A, Asarnoj, A, et al. Allergy. First published: 05 November 2021
-
Assessment of biomarkers in pediatric atopic dermatitis by tape strips and skin biopsies
Andersson, A.M., Sølberg, J., Koch, A., et al. Allergy. First published: 25 October 2021
-
Transcriptome-based identification of novel endotypes in adult atopic dermatitis
Lefèvre-Utile, A., Saichi, M., Oláh, P., et al. Allergy. First published: 24 October 2021
-
The benefit of late readings in patch testing depends both on allergen and patient characteristics
Forkel, S., Schubert, S., Dickel, H., et al. Allergy. First published: 23 October 2021
-
Specific T cells targeting Staphylococcus aureus Fibronectin-binding protein 1 induce a type 2/type 1 inflammatory response in sensitized atopic dermatitis patients
Farag, A.K., Roesner, L.M., Wieschowski, S., et al. Allergy. First published: 03 October 2021
-
Phase 2a randomized clinical trial of dupilumab (anti-IL-4Rα) for alopecia areata patients
Guttman-Yassky, E, Renert-Yuval, Y, Bares, J, et al. Allergy. First published: 30 August 2021
-
Increasing severity of early-onset atopic dermatitis, but not late-onset, associates with development of aeroallergen sensitization and allergic rhinitis in childhood
Schoos, A-MM, Chawes, BL, Bønnelykke, K, Stokholm, J, Rasmussen, MA, Bisgaard, H. Allergy. First published: 24 September 2021
-
Identification of novel biomarkers to distinguish bradykinin-mediated angioedema from mast cell-/histamine-mediated angioedema
Bindke, G., Gehring, M., Wieczorek, D., Kapp, A., Buhl, T. and Wedi, B. Allergy. First published: 20 July 2021
-
Long-term prevention of hereditary angioedema attacks with lanadelumab: the HELP OLE Study
Banerji, A., Bernstein, J.A., Johnston, D.T., et al. Allergy. First published: 21 July 2021
-
The maternal diet index in pregnancy is associated with offspring allergic diseases: the Healthy Start study
Venter, C, Palumbo, MP, Glueck, DH, et al.Allergy. First published: 22 May 2021
-
Environment-dependent alterations of immune mediators in urban and rural south African children with atopic dermatitis
Lunjani, N, Tan, G, Dreher, A, et al. Allergy. 2022; 77: 569– 581
-
MR1-dependent immune surveillance of the skin contributes to pathogenesis and is a photobiological target of UV light therapy in a mouse model of atopic dermatitis.
Naidoo, K., Woods, K., Pellefigues, C., et al. Allergy. 2021; 76: 3155-3170
-
Free human DNA attenuates the activity of antimicrobial peptides in atopic dermatitis
Kopfnagel, V., Dreyer, S., Zeitvogel, J., et al. Allergy. 2021; 76: 3145-3154
-
Effects of pregnancy on chronic urticaria: Results of the PREG-CU UCARE study
Kocatürk, E, Al-Ahmad, M, Krause, K, et al. Allergy. 2021; 76: 3133-3144
-
Prenatal paraben exposure and atopic dermatitis-related outcomes among children
Thürmann, L., Herberth, G., Seiwert, B., et al. Allergy. 2021; 76: 3122-3132
-
Vascular inflammation in moderate-to-severe atopic dermatitis is associated with enhanced Th2 response
Villani, A.P., Pavel, A.B., Wu, J., et al. Allergy. 2021; 76: 3107-3121
-
Direct assessment of individual skin barrier components by electrical impedance spectroscopy
Mannweiler, R., Bergmann, S., Vidal-y-Sy, S., Brandner, J.M. and Günzel, D. Allergy. 2021; 76: 3094-3106
-
High-dimensional analysis defines multicytokine T-cell subsets and supports a role for IL-21 in atopic dermatitis
Czarnowicki, T., Kim, H.J., Villani, et al. Allergy. 2021; 76: 3080-3093
-
Electrical impedance spectroscopy for the characterization of skin barrier in atopic dermatitis
Rinaldi, A.O., Korsfeldt, A., Ward, S. et al. Allergy. 2021; 76: 3066-3079
-
An integrated scalp and blood biomarker approach suggeststhe systemic nature of alopecia areata
Glickman, J.W., Dubin, C., Dahabreh, D., et al. Allergy. 2021; 76: 3053-3065
-
Prevalence and early-life risk factors of school-age allergic multimorbidity: The EuroPrevall-iFAAM birth cohort
Sigurdardottir, ST, Jonasson, K, Clausen, M, et al. Allergy. 2021; 76: 2855– 2865
-
Impact of anxiety, stress and depression related to COVID-19 pandemic on the course of hereditary angioedema with C1 inhibitor deficiency
Eyice Karabacak, D., Demir, S., Yeğit, O.O., et al. Allergy.2021; 76: 2535-2543
-
Association between ambient air pollution and development and persistence of atopic and non-atopic eczema in a cohort of adults
Lopez, D.J., Lodge, C.J., Bui, D.S., et al. Allergy.2021; 76: 2524-2534
-
Whole genome sequencing identifies novel genetic mutations in patients with eczema herpeticum
Bin, L., Malley, C., Taylor, P., et al. Allergy.2021; 76: 2510-2523
-
Skewed inflammation is associated with aberrant interleukin-37 signaling pathway in atopic dermatitis
Hou, T., Tsang, M.S.-M., Chu, et al. Allergy.2021; 76: 2102-2114
-
Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry
Chiricozzi, A., Talamonti, M., De Simone, C., et al. Allergy. 2021; 76: 1813-1824
-
Oral berotralstat for the prophylaxis of hereditary angioedema attacks in patients in Japan: A phase 3 randomized trial
Ohsawa, I., Honda, D., Suzuki, Y., Allergy.2021; 76: 1789-1799
-
https://onlinelibrary.wiley.com/doi/10.1111/all.14692
Fatty acid-binding protein 3 controls contact hypersensitivity through regulating skin dermal Vγ4+ γ/δ T cell in a murine model
Kobayashi, S, Phung, HT, Kagawa, Y, et al. et al. Allergy. 2021; 76: 1776.1788
-
Impact of lanadelumab on health-related quality of life in patients with hereditary angioedema in the HELP study
Lumry, W.R., Weller, K., Magerl, M., et al. Allergy.2021; 76: 1188-1198
-
Microbial and transcriptional differences elucidate atopic dermatitis heterogeneity across skin sites
Ottman, N, Barrientos-Somarribas, M, Fyhrquist, N, et al. Allergy. 2021; 76: 1173– 1187
-
Predicting persistence of atopic dermatitis in children using clinical attributes and serum proteins
Lauffer, F, Baghin, V, Standl, M, et al. Allergy. 2021; 76: 1158– 1172
-
The global impact of the COVID-19 pandemic on the management and course of chronic urticaria
Kocatürk, E, Salman, A, Cherrez-Ojeda, I, et al. Allergy. 2021; 76: 816– 830
-
Integrative transcriptome analysis deciphers mechanisms of nickel contact dermatitis
Wisgrill, L, Werner, P, Jalonen, E, et al. Allergy. 2021; 76: 804– 815
-
Tape strips from early-onset pediatric atopic dermatitis highlight disease abnormalities in nonlesional skin
Pavel A. B., Renert- Yuval, Y., Wu, J., et al. Allergy. 2021; 76: 314- 325
-
Biofilm propensity of Staphylococcus aureus skin isolates is associated with increased atopic dermatitis severity and barrier dysfunction in the MPAACH pediatric cohort
Gonzalez T., Stevens, M. L., Baatyrbek Kyzy, A., et al. Allergy. 2021; 76:302- 313
-
Inhibition of mite-induced dermatitis, pruritus, and nerve sprouting in mice by the endothelin receptor antagonist bosentan
Kido-Nakahara M., Wang, B., Ohno, F., et al. Allergy. 2021; 76: 291- 301
-
Dysregulated skin barrier function in Tmem79 mutant mice promotes IL-17A-dependent spontaneous skin and lung inflammation
Saunders, SP, Floudas, A, Moran, T, et al. Allergy. 2020; 75: 3216– 3227
-
IgM and IgA in addition to IgG autoantibodies against FcɛRIα are frequent and associated with disease markers of chronic spontaneous urticaria
Altrichter, S, Zampeli, V, Ellrich, A, Zhang, K, Church, MK, Maurer, M. Allergy. 2020; 75: 3208– 3215
-
Skin pH–dependent Staphylococcus aureus abundance as predictor for increasing atopic dermatitis severity
Hülpüsch, C, Tremmel, K, Hammel, G, et al. Allergy. 2020; 75: 2888– 2898
-
Lanadelumab demonstrates rapid and sustained prevention of hereditary angioedema attacks
Riedl, MA, Maurer, M, Bernstein, JA, et al. Allergy. 2020; 75: 2879– 2887
-
Skin-infiltrating basophils promote atopic dermatitis-like inflammation via IL-4 production in mice
Yamanishi, Y, Mogi, K, Takahashi, K, Miyake, K, Yoshikawa, S, Karasuyama, H. Allergy. 2020; 75: 2613– 2622
-
Orally applied bacterial lysate in infants at risk for atopy does not prevent atopic dermatitis, allergic rhinitis, asthma or allergic sensitization at school age: Follow-up of a randomized trial
Roßberg, S, Keller, T, Icke, K, et al. Allergy. 2020; 75: 2020– 2025
-
Maternal ω3 docosapentaenoic acid inhibits infant allergic dermatitis through TRAIL-expressing plasmacytoid dendritic cells in mice
Hirata, S-I, Nagatake, T, Sawane, K, et al. Allergy. 2020; 75: 1939– 1955
-
Comel-Netherton syndrome: A local skin barrier defect in the absence of an underlying systemic immunodeficiency
Stuvel, K, Heeringa, JJ, Dalm, VASH, et al. Allergy. 2020; 75: 1710– 1720
-
Impaired control of the contact system in hereditary angioedema with normal C1-inhibitor
Bova, M, Suffritti, C, Bafunno, V, et al. Allergy. 2020; 75: 1394– 1403
-
Development of the angioedema control test-A patient-reported outcome measure that assesses disease control in patients with recurrent angioedema
Weller, K, Donoso, T, Magerl, M, et al. Allergy. 2020; 75: 1165– 1177
-
Interleukin 31 in insect bite hypersensitivity-Alleviating clinical symptoms by active vaccination against itch
Olomski, F, Fettelschoss, V, Jonsdottir, S, et al. Allergy. 2020; 75: 862– 871
-
Prevalence of chronic urticaria in children and adults across the globe: Systematic review with meta-analysis
Fricke, J, Ávila, G, Keller, T, et al. Allergy. 2020; 75: 423– 432
-
Exonic mutations associated with atopic dermatitis disrupt lympho-epithelial kazal-type related inhibitor action and enhance its degradation
Ramesh, K, Matta, SA, Chew, FT, Mok, YK. Allergy. 2020; 75: 403– 411
-
Postnatal probiotics and allergic disease in very preterm infants: Sub-study to the ProPrems randomized trial
Plummer, EL, Chebar Lozinsky, A, Tobin, JM, et al. Allergy. 2020; 75: 127– 136
-
Dupilumab is very effective in a large cohort of difficult-to-treat adult atopic dermatitis patients: First clinical and biomarker results from the BioDay registry
Ariëns, LFM, van der Schaft, J, Bakker, DS, et al. Allergy. 2020; 75: 116– 126
-
Markers of microbial exposure lower the incidence of atopic dermatitis
Chatenoud, L, Bertuccio, P, Turati, F, et al. Allergy. 2020; 75: 104– 115
-
Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: Results of the PURIST Study
Schoepke, N, Asero, R, Ellrich, A, et al. Allergy. 2019; 74: 2427– 2436
-
miR-10a-5p is increased in atopic dermatitis and has capacity to inhibit keratinocyte proliferation
Vaher, H, Runnel, T, Urgard, E, et al. Allergy. 2019; 74: 2146– 2156
-
Direct assessment of skin epithelial barrier by electrical impedance spectroscopy
Rinaldi, AO, Morita, H, Wawrzyniak, P, et al. Allergy. 2019; 74: 1934– 1944
-
Spontaneous atopic dermatitis in mice with a defective skin barrier is independent of ILC2 and mediated by IL-1β
Schwartz, C, Moran, T, Saunders, SP, et al. Allergy. 2019; 74: 1920– 1933
-
Langerhans cells mediate the skin-induced tolerance to ovalbumin via Langerin in a murine model
Luo, Y, Wang, S, Liu, X, Wen, H, Li, W, Yao, X. Allergy. 2019; 74: 1738– 1747
-
Pruritus in ordinary scabies: IL-31 from macrophages induced by overexpression of thymic stromal lymphopoietin and periostin
Hashimoto, T, Satoh, T, Yokozeki, H. Allergy. 2019; 74: 1727– 1737
-
Transient epidermal barrier deficiency and lowered allergic threshold in filaggrin‐hornerin (FlgHrnr−/−) double‐deficient mice
Rahrig, S, Dettmann, JM, Brauns, B, et al. Allergy. 2019; 74: 1327– 1339
-
Eicosanoid mediator profiles in different phenotypes of nonsteroidal anti-inflammatory drug-induced urticaria
Doña, I, Jurado-Escobar, R, Perkins, JR, et al. Allergy. 2019; 74: 1135– 1144
-
Quantitative profiling of cytokines and chemokines in DOCK8-deficient and atopic dermatitis patients
Jacob, M, Bin Khalaf, D, Alhissi, S, et al. Allergy. 2019; 74: 370– 379